⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CERO News
CERo Therapeutics Holdings, Inc. Common Stock
CERo Therapeutics Doses Second Patient in Cohort 2 of Phase 1 CER-1236 Trial
globenewswire.com
CERO
CERo Therapeutics Doses Second Patient in Cohort 2 of Phase 1 CER-1236 Trial
globenewswire.com
CERO
CERo Therapeutics Provides Shareholder Update
globenewswire.com
CERO
CERo Therapeutics Provides Shareholder Update
globenewswire.com
CERO
Form 8-K
sec.gov
CERO
CEROW
CERo Therapeutics to Present Late-Breaking Oral Poster Session Highlighting Interim Phase 1 Data from CERTAIN-T Trial Highlighting Platelet Transfusion Independence in a High-Risk MDS/AML Patient
globenewswire.com
CERO
CERo Therapeutics Provides Clinical Update on Phase 1 Trial of CER-1236 in AML (CertainT-1) Highlighting Key Safety Data and Platelet Transfusion–Free Interval Observed in a Patient with Myelodysplastic Syndrome/AML
globenewswire.com
CERO
CERo Therapeutics Provides Clinical Update on Phase 1 Clinical Trial of CER-1236 in AML (CertainT-1)
globenewswire.com
CERO
City of Quincy Partners with Cero Global to Launch Pilot Reducing Emissions and Fuel Costs
prnewswire.com
CERO
CERo Therapeutics Announces Trading on OTCQB Market
globenewswire.com
CERO